Western blotting revealed that PAH treatment significantly decreased intracellular levels of GPX4 and SLC7A11, while increasing protein expression of transferrin receptor (TFRC), ferritin heavy chain (FTH1), and ferritin light chain (FTL). The gene discussed is FTH1; the disease is pulmonary arterial hypertension.